Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Sci. Signal., 13 May 2008
Vol. 1, Issue 19, p. ec173
[DOI: 10.1126/stke.119ec173]

EDITORS' CHOICE

Cell Cycle Balancing Act

John F. Foley

Science Signaling, AAAS, Washington, DC 20005, USA

The tumor suppressor protein p53 responds to such cell stress-inducing stimuli as DNA damage and hypoxia. The resulting nuclear accumulation of p53 triggers the repression or activation of the appropriate genes to lead to apoptosis or cell-cycle arrest, thus halting cell proliferation. In a search for new p53 target genes, Basak et al. exposed various primary cell types from wild-type or p53-deficient mice to DNA-damaging stimuli such as Doxorubicin or {gamma} irradiation. Microarray analyses showed that expression of the gene Prl-3 was induced by these stimuli in a p53-dependent manner, and Western blotting showed that Prl-3 protein increased in abundance accordingly. This was unexpected because Prl-3, a protein phosphatase, is known to promote tumor metastasis. Chromatin immunoprecipitation assays demonstrated that p53 bound to Prl-3, and reporter assays in wild-type and p53-deficient mouse embryo fibroblasts (MEFs) showed that Prl-3 was a transcriptional target of p53. Proliferation assays showed that Prl-3, when overexpressed in MEFs, triggered cell-cycle arrest but not apoptosis. Western blotting analysis demonstrated that overexpression of Prl-3 in human fibrosarcoma cells initially led to activation of the kinase Akt, which is known to enhance cell proliferation. However, as Prl-3 abundance increased with time, it inhibited Akt activity through a negative-feedback mechanism, leading to cell-cycle arrest. Indeed, Prl-3 could not induce cell-cycle arrest in Akt-deficient MEFs. To add even more complexity, knockdown of Prl-3 in MEFs also led to cell-cycle arrest, in a p53-dependent manner. Together, these data suggest that the abundance of Prl-3, a new target of p53 (see commentary by Hinds), must be tightly controlled for normal cell-cycle progression.

S. Basak, S. B. R. Jacobs, A. J. Krieg, N. Pathak, Q. Zeng, P. Kaldis, A. J. Giaccia, L. D. Attardi, The metastasis-associated gene Prl-3 is a p53 target involved in cell-cycle regulation. Mol. Cell 30, 303-314 (2008). [PubMed]

P. W. Hinds, Too much of a good thing: The Prl-3 in p53’s oyster. Mol. Cell 30, 260-261 (2008). [PubMed]

Citation: J. F. Foley, Balancing Act. Sci. Signal. 1, ec173 (2008).



To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882